{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:45:42Z","timestamp":1775328342567,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0640"],"award-info":[{"award-number":["W81XWH-16-1-0640"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["pilot award from MCRC P60 AR062755 grant"],"award-info":[{"award-number":["pilot award from MCRC P60 AR062755 grant"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20 RR017677"],"award-info":[{"award-number":["P20 RR017677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 RR031535"],"award-info":[{"award-number":["S10 RR031535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230499","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T17:39:39Z","timestamp":1584553179000},"page":"e0230499","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL\/lpr lupus mice"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-5415","authenticated-orcid":true,"given":"Tamara K.","family":"Nowling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessalyn","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumagal","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Bruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamala","family":"Sundararaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Molano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Gilkeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"3","key":"pone.0230499.ref001","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.40729","article-title":"All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014","volume":"71","author":"A Jorge","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"pone.0230499.ref002","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"TM Chan","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5","key":"pone.0230499.ref003","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2012.11.042","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study","volume":"61","author":"M Walsh","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0230499.ref004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"FA Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"pone.0230499.ref005","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.M049189","article-title":"Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles","volume":"55","author":"KJ Grove","year":"2014","journal-title":"Journal of lipid research"},{"issue":"3","key":"pone.0230499.ref006","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1152\/ajprenal.00150.2015","article-title":"Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells","volume":"309","author":"M Subathra","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"pone.0230499.ref007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"TA Natoli","year":"2010","journal-title":"Nat Med"},{"issue":"15","key":"pone.0230499.ref008","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/hmg\/dds172","article-title":"Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease","volume":"21","author":"TA Natoli","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"10","key":"pone.0230499.ref009","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1194\/jlr.M040014","article-title":"MALDI imaging MS reveals candidate lipid markers of polycystic kidney disease","volume":"54","author":"H Ruh","year":"2013","journal-title":"Journal of lipid research"},{"issue":"6","key":"pone.0230499.ref010","doi-asserted-by":"crossref","first-page":"e20411","DOI":"10.1371\/journal.pone.0020411","article-title":"Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction","volume":"6","author":"MJ Hernandez-Corbacho","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"pone.0230499.ref011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000444926","article-title":"Targeting Glycosphingolipid Metabolism to Treat Kidney Disease","volume":"134","author":"JA Shayman","year":"2016","journal-title":"Nephron"},{"issue":"2","key":"pone.0230499.ref012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semnephrol.2018.01.007","article-title":"Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease","volume":"38","author":"JA Shayman","year":"2018","journal-title":"Semin Nephrol"},{"issue":"6","key":"pone.0230499.ref013","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1681\/ASN.2014050508","article-title":"Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis","volume":"26","author":"TK Nowling","year":"2015","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"4","key":"pone.0230499.ref014","doi-asserted-by":"crossref","first-page":"F630","DOI":"10.1152\/ajprenal.00421.2017","article-title":"Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells","volume":"314","author":"K Sundararaj","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"pone.0230499.ref015","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","article-title":"Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease","volume":"37","author":"S Chatterjee","year":"1996","journal-title":"Journal of lipid research"},{"issue":"4","key":"pone.0230499.ref016","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1046\/j.1523-1755.2001.00967.x","article-title":"Ganglioside as an endogenous growth suppressor for glomerular mesangial cells","volume":"60","author":"N Tsuboi","year":"2001","journal-title":"Kidney international"},{"issue":"2","key":"pone.0230499.ref017","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","article-title":"Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function","volume":"151","author":"J Jin","year":"2012","journal-title":"Cell"},{"issue":"24","key":"pone.0230499.ref018","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/febs.12559","article-title":"Glycosphingolipids: synthesis and functions","volume":"280","author":"G D'Angelo","year":"2013","journal-title":"FEBS J"},{"issue":"Suppl 1","key":"pone.0230499.ref019","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic","volume":"55","author":"P Ward","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"pone.0230499.ref020","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.178.5.2651","article-title":"Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity","volume":"178","author":"ML Moore","year":"2007","journal-title":"Journal of immunology"},{"issue":"1","key":"pone.0230499.ref021","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1038\/s41598-017-15198-8","article-title":"Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model","volume":"7","author":"TR Karhadkar","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0230499.ref022","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1194\/jlr.D800051-JLR200","article-title":"Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers","volume":"50","author":"RL Shaner","year":"2009","journal-title":"Journal of lipid research"},{"issue":"3","key":"pone.0230499.ref023","first-page":"352","article-title":"Measurement of creatinine by Jaffe's reaction\u2014determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum","volume":"40","author":"BD Toora","year":"2002","journal-title":"Indian J Exp Biol"},{"issue":"9","key":"pone.0230499.ref024","doi-asserted-by":"crossref","first-page":"e75175","DOI":"10.1371\/journal.pone.0075175","article-title":"Reducing FLI1 levels in the MRL\/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism","volume":"8","author":"EM Richard","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"pone.0230499.ref025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1134\/S0006297909030018","article-title":"Ganglioside GM3 and its biological functions","volume":"74","author":"NV Prokazova","year":"2009","journal-title":"Biochemistry (Mosc)"},{"issue":"8","key":"pone.0230499.ref026","doi-asserted-by":"crossref","first-page":"e43310","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"MA Cabrera-Salazar","year":"2012","journal-title":"PloS one"},{"issue":"26","key":"pone.0230499.ref027","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis","volume":"112","author":"JC Dodge","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"pone.0230499.ref028","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus","volume":"113","author":"EC Jury","year":"2004","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"pone.0230499.ref029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellimm.2004.04.001","article-title":"Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB\/NZW F1 mice","volume":"228","author":"D Sun","year":"2004","journal-title":"Cell Immunol"},{"key":"pone.0230499.ref030","doi-asserted-by":"crossref","first-page":"569053","DOI":"10.1155\/2010\/569053","article-title":"Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients","volume":"2010","author":"L Dong","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"pone.0230499.ref031","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI69571","article-title":"Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients","volume":"124","author":"G McDonald","year":"2014","journal-title":"The Journal of clinical investigation"},{"issue":"12","key":"pone.0230499.ref032","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1500961","article-title":"FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL\/lpr Lupus Mouse Strain","volume":"195","author":"KP Sundararaj","year":"2015","journal-title":"Journal of immunology"},{"issue":"12","key":"pone.0230499.ref033","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/glycob\/9.12.1313","article-title":"Expression of a novel human sialidase encoded by the NEU2 gene","volume":"9","author":"E Monti","year":"1999","journal-title":"Glycobiology"},{"issue":"Pt 1","key":"pone.0230499.ref034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20050017","article-title":"Evidence for mitochondrial localization of a novel human sialidase (NEU4)","volume":"390","author":"K Yamaguchi","year":"2005","journal-title":"Biochem J"},{"issue":"7","key":"pone.0230499.ref035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10719-011-9350-5","article-title":"Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors","volume":"28","author":"AV Pshezhetsky","year":"2011","journal-title":"Glycoconj J"},{"issue":"12","key":"pone.0230499.ref036","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/hmg\/11.12.1455","article-title":"Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice","volume":"11","author":"N de Geest","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"9","key":"pone.0230499.ref037","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10719-009-9239-8","article-title":"Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase","volume":"26","author":"SR Amith","year":"2009","journal-title":"Glycoconj J"},{"issue":"43","key":"pone.0230499.ref038","doi-asserted-by":"crossref","DOI":"10.3791\/2142","article-title":"Detection of Neu1 sialidase activity in regulating Toll-like receptor activation","author":"SR Amith","year":"2010","journal-title":"J Vis Exp"},{"issue":"42","key":"pone.0230499.ref039","doi-asserted-by":"crossref","first-page":"36532","DOI":"10.1074\/jbc.M111.237578","article-title":"Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling","volume":"286","author":"S Abdulkhalek","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"11","key":"pone.0230499.ref040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.cellsig.2012.06.016","article-title":"G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling","volume":"24","author":"S Abdulkhalek","year":"2012","journal-title":"Cell Signal"},{"issue":"11","key":"pone.0230499.ref041","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.cellsig.2013.06.010","article-title":"Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses","volume":"25","author":"S Abdulkhalek","year":"2013","journal-title":"Cell Signal"},{"issue":"6","key":"pone.0230499.ref042","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cellsig.2014.02.015","article-title":"A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes","volume":"26","author":"F Alghamdi","year":"2014","journal-title":"Cell Signal"},{"key":"pone.0230499.ref043","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"J Li","year":"2015","journal-title":"Nat Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T23:38:07Z","timestamp":1614901087000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230499"}},"subtitle":[],"editor":[{"given":"Jose C.","family":"Crispin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230499","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]}}}